Decision making in health and medicine: Integrating evidence and values, second edition

Decision making in health care involves consideration of a complex set of diagnostic, therapeutic and prognostic uncertainties. Medical therapies have side effects, surgical interventions may lead to complications, and diagnostic tests can produce misleading results. Furthermore, patient values and service costs must be considered. Decisions in clinical and health policy require careful weighing of risks and benefits and are commonly a trade-off of competing objectives: maximizing quality of life vs maximizing life expectancy vs minimizing the resources required. This text takes a proactive, systematic and rational approach to medical decision making. It covers decision trees, Bayesian revision, receiver operating characteristic curves, and cost-effectiveness analysis; as well as advanced topics such as Markov models, microsimulation, probabilistic sensitivity analysis and value of information analysis. It provides an essential resource for trainees and researchers involved in medical decision modelling, evidence-based medicine, clinical epidemiology, comparative effectiveness, public health, health economics, and health technology assessment.

[1]  Anthony J. Culyer,et al.  Cost-effectiveness Analysis Registry , 2014 .

[2]  Ralph Pinnock,et al.  Learning clinical reasoning , 2014, Journal of paediatrics and child health.

[3]  Joseph A Hill.  United States Life Tables , 2013 .

[4]  H. Kamel,et al.  Paroxysmal Supraventricular Tachycardia and the Risk of Ischemic Stroke , 2013, Stroke.

[5]  R. Rosenfeld,et al.  The diagnosis and management of acute otitis media. , 2013, Pediatrics.

[6]  M. Pencina,et al.  Evaluation of Markers and Risk Prediction Models , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  J. Brazier,et al.  Does the EQ-5D Reflect Lost Earnings? , 2012, PharmacoEconomics.

[8]  Ersen B. Colkesen,et al.  Validation of a model to investigate the effects of modifying cardiovascular disease (CVD) risk factors on the burden of CVD: the rotterdam ischemic heart disease and stroke computer simulation (RISC) model , 2012, BMC Medicine.

[9]  Theo Stijnen,et al.  Methods for calculating sensitivity and specificity of clustered data: a tutorial. , 2012, Radiology.

[10]  D. D. Des Jarlais,et al.  Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. , 2012, Addiction.

[11]  E. Elbasha,et al.  PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE) , 2012 .

[12]  D. Andreini,et al.  Radiation dose and diagnostic accuracy of multidetector computed tomography for the detection of significant coronary artery stenoses: a meta-analysis. , 2012, International journal of cardiology.

[13]  Milton C. Weinstein,et al.  Incorporating Calibrated Model Parameters into Sensitivity Analyses , 2012, PharmacoEconomics.

[14]  Eve Wittenberg,et al.  Health Utility Elicitation , 2012, PharmacoEconomics.

[15]  Jonathan Karnon,et al.  Modeling Using Discrete Event Simulation , 2012 .

[16]  Douglas K Owens,et al.  State-Transition Modeling , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  Mirjam Kretzschmar,et al.  Dynamic Transmission Modeling , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  Jonathan Karnon,et al.  Model Parameter Estimation and Uncertainty Analysis , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[19]  Murray Krahn,et al.  Conceptualizing a Model , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  William Hollingworth,et al.  Model Transparency and Validation , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[21]  Filippo Cademartiri,et al.  Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts , 2012, BMJ : British Medical Journal.

[22]  M. Buxton,et al.  Factors Predicting Medicare National Coverage: An Empirical Analysis , 2012, Medical Care.

[23]  Sylvia K Plevritis,et al.  Online tool to guide decisions for BRCA1/2 mutation carriers. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Drummond.  Twenty Years of Using Economic Evaluations for Reimbursement Decisions. What Have We Achieved , 2012 .

[25]  Marc A. Koopmanschap,et al.  An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare , 2008, PharmacoEconomics.

[26]  David Feeny,et al.  Multi-Attribute Preference Functions , 1995, PharmacoEconomics.

[27]  George W. Torrance,et al.  Multi-Attribute Health Status Classification Systems , 1995, PharmacoEconomics.

[28]  A. Harris,et al.  Cost-Effectiveness Analysis and the Consistency of Decision Making , 2012, PharmacoEconomics.

[29]  Natasha K. Stout,et al.  Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines , 2012, PharmacoEconomics.

[30]  Richard G. White,et al.  Calibrating Models in Economic Evaluation , 2012, PharmacoEconomics.

[31]  Vivek Pawar,et al.  Methods of Model Calibration , 2012, PharmacoEconomics.

[32]  L. Prosser,et al.  Methods for Measuring Temporary Health States for Cost-Utility Analyses , 2012, PharmacoEconomics.

[33]  A. Bayoumi.  The Measurement of Contingent Valuation for Health Economics , 2012, PharmacoEconomics.

[34]  Milton C. Weinstein,et al.  Recent Developments in Decision-Analytic Modelling for Economic Evaluation , 2012, PharmacoEconomics.

[35]  J. Caro,et al.  Pharmacoeconomic analyses using discrete event simulation , 2012, PharmacoEconomics.

[36]  J. Louviere,et al.  Conducting Discrete Choice Experiments to Inform Healthcare Decision Making , 2012, PharmacoEconomics.

[37]  P. Dolan.  Thinking about it: thoughts about health and valuing QALYs. , 2011, Health economics.

[38]  Johannes B. Reitsma,et al.  Clinical Decision Rules for Excluding Pulmonary Embolism: A Meta-analysis , 2011, Annals of Internal Medicine.

[39]  Marvin Zelen,et al.  Modeling the impact of population screening on breast cancer mortality in the United States. , 2011, Breast.

[40]  S. Bates.  Pregnancy-associated venous thromboembolism: prevention and treatment. , 2011, Seminars in hematology.

[41]  H. D. de Koning,et al.  Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals , 2011, British Journal of Cancer.

[42]  Neff Walker,et al.  Mathematical models in the evaluation of health programmes , 2011, The Lancet.

[43]  L. Goldman,et al.  Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era , 2011, Circulation.

[44]  L. Prosser,et al.  Ordering errors, objections and invariance in utility survey responses , 2011, Applied health economics and health policy.

[45]  Milton C Weinstein,et al.  Calibrating longitudinal models to cross-sectional data: the effect of temporal changes in health practices. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[46]  Theo Stijnen,et al.  The Combined Analysis of Uncertainty and Patient Heterogeneity in Medical Decision Models , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[47]  Cathal Walsh,et al.  Bayesian Calibration of a Natural History Model with Application to a Population Model for Colorectal Cancer , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[48]  David Hammond,et al.  The impact of cigarette pack design, descriptors, and warning labels on risk perception in the U.S. , 2011, American journal of preventive medicine.

[49]  Rhonda K. Dailey,et al.  Men's perspectives on selecting their prostate cancer treatment. , 2011, Journal of the National Medical Association.

[50]  M. Drummond,et al.  Another special relationship? Interactions between health technology policies and health care systems in the United States and the United Kingdom. , 2011, Journal of health politics, policy and law.

[51]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[52]  R. S. Porter,et al.  The Merck manual of diagnosis and therapy, 19th ed. , 2011 .

[53]  S. Palmer,et al.  The CHD challenge: comparing four cost-effectiveness models. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[54]  Karl Claxton,et al.  Discounting and decision making in the economic evaluation of health-care technologies. , 2011, Health economics.

[55]  D. Kahneman.  Thinking, Fast and Slow , 2011 .

[56]  M. Drummond,et al.  What do international pharmacoeconomic guidelines say about economic data transferability? , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[57]  Dorte Gyrd-Hansen,et al.  Future costs in cost-effectiveness analysis: an empirical assessment , 2010, The European Journal of Health Economics.

[58]  S. Pauker.  Medical Decision Making: How Patients Choose , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[59]  A. Partin,et al.  Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. , 2010, Urology.

[60]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[61]  Oguzhan Alagoz,et al.  Markov Decision Processes: A Tool for Sequential Decision Making under Uncertainty , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[62]  D. Feeny,et al.  QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique , 2010, Expert review of pharmacoeconomics & outcomes research.

[63]  M. Meltzer,et al.  Estimating the risk of rabies transmission to humans in the U.S.: a delphi analysis , 2010, BMC public health.

[64]  J. Brazier,et al.  In or out? Income losses in health state valuations: a review. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[65]  M G Myriam Hunink,et al.  Uncertainty and Patient Heterogeneity in Medical Decision Models , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[66]  A. Tsuchiya,et al.  Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[67]  S. Plevritis,et al.  Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[69]  Simon G Thompson,et al.  Uncertainty and validation of health economic decision models. , 2009, Health economics.

[70]  Aki Tsuchiya,et al.  A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures , 2010, The European Journal of Health Economics.

[71]  L. Hedges,et al.  The Handbook of Research Synthesis and Meta-Analysis , 2009 .

[72]  J. Savarino,et al.  Bayesian Calibration of Microsimulation Models , 2009, Journal of the American Statistical Association.

[73]  Ian Harvey,et al.  Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies , 2009, BMC medical research methodology.

[74]  S. Baker.  Putting risk prediction in perspective: relative utility curves. , 2009, Journal of the National Cancer Institute.

[75]  M. Airoldi,et al.  Adjusting life for quality or disability: stylistic difference or substantial dispute? , 2009, Health economics.

[76]  S. Goldie,et al.  Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States , 2009, Annals of Internal Medicine.

[77]  Nancy R Cook,et al.  Using relative utility curves to evaluate risk prediction , 2009, Journal of the Royal Statistical Society. Series A,.

[78]  Elizabeth Wilcox.  Decisions for dummies , 2009, Canadian Medical Association Journal.

[79]  O. Dekkers,et al.  Safety of ruling out acute pulmonary embolism by normal computed tomography pulmonary angiography in patients with an indication for computed tomography: systematic review and meta‐analysis , 2009, Journal of thrombosis and haemostasis : JTH.

[80]  Benjamin M Craig,et al.  Modeling Ranking, Time Trade-Off, and Visual Analog Scale Values for EQ-5D Health States: A Review and Comparison of Methods , 2009, Medical care.

[81]  G Scott Gazelle,et al.  Calibration of disease simulation model using an engineering approach. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[82]  Mark Sculpher,et al.  Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[83]  M. Drummond,et al.  Public funding of new cancer drugs: Is NICE getting nastier? , 2009, European journal of cancer.

[84]  Benjamin M Craig,et al.  Keep it simple: ranking health states yields values similar to cardinal measurement approaches. , 2009, Journal of clinical epidemiology.

[85]  Ewout Steyerberg,et al.  Net reclassification improvement and decision theory , 2009, Statistics in medicine.

[86]  B. Gage,et al.  Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation , 2009, Annals of Internal Medicine.

[87]  M. Rawlins.  De testimonio: on the evidence for decisions about the use of therapeutic interventions , 2008, The Lancet.

[88]  Suzanne O'Neill,et al.  Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[89]  Elena B. Elkin,et al.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers , 2008, BMC Medical Informatics Decis. Mak..

[90]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[91]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[92]  M. Weinstein,et al.  MO2 INCORPORATING CALIBRATED MODEL PARAMETERS INTO SENSITIVITY ANALYSES: DETERMINISTIC AND PROBABILISTIC APPROACHES , 2008 .

[93]  Joanna Coast,et al.  Rescaling quality of life values from discrete choice experiments for use as QALYs: a cautionary tale , 2008, Population health metrics.

[94]  E. Steyerberg.  Clinical Prediction Models , 2008, Statistics for Biology and Health.

[95]  J. C. Houwelingen,et al.  Bivariate Random Effects Meta-Analysis of ROC Curves , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[96]  C. Earle,et al.  Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  Dorota Kurowicka,et al.  Uncertainty and Sensitivity Analyses of a Dynamic Economic Evaluation Model for Vaccination Programs , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[98]  Theo Stijnen,et al.  Value of information analysis used to determine the necessity of additional research: MR imaging in acute knee trauma as an example. , 2008, Radiology.

[99]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[100]  A. Ferrer-i-Carbonell,et al.  Monetary valuation of informal care: the well-being valuation method. , 2007, Health economics.

[101]  Ian J. Bateman,et al.  The Affect Heuristic and the Attractiveness of Simple Gambles , 2007 .

[102]  P. Stalmeier,et al.  On the Assessment of Preferences for Health and Duration: Maximal Endurable Time and Better Than Dead Preferences , 2007, Medical care.

[103]  Karen M Kuntz,et al.  Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.

[104]  Jeffrey A. Johnson,et al.  A Comparison of EQ-5D Index Scores Derived from the US and UK Population-Based Scoring Functions , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[105]  Bas Groot Koerkamp,et al.  Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[106]  Noel T Brewer,et al.  The Influence of Irrelevant Anchors on the Judgments and Choices of Doctors and Patients , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[107]  Anirban Basu,et al.  Value of Information on Preference Heterogeneity and Individualized Care , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[108]  G. Salkeld.  Valuing health for regulatory cost-effectiveness analysis , 2007 .

[109]  Andrew Briggs,et al.  The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm , 2007, Journal of health services research & policy.

[110]  J. Concato,et al.  Treatment Decisions for Localized Prostate Cancer Asking Men What ’ s Important , 2000 .

[111]  Hal R. Arkes,et al.  Systematic errors in medical decision making: , 1987, Journal of General Internal Medicine.

[112]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[113]  Natasha K. Stout,et al.  Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .

[114]  Karl Claxton,et al.  Probabilistic analysis and computationally expensive models: Necessary and required? , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[115]  D. Fryback,et al.  Relative Disutilities of 47 Risk Factors and Conditions Assessed with Seven Preference-Based Health Status Measures in a National U.S. Sample: Toward Consistency in Cost-Effectiveness Analyses , 2006, Medical care.

[116]  Theo Stijnen,et al.  Apparent and Internal Validity of a Monte Carlo–Markov Model for Cardiovascular Disease in a Cohort Follow-up Study , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[117]  A James O'Malley,et al.  Bayesian multivariate hierarchical transformation models for ROC analysis , 2006, Statistics in medicine.

[118]  Vipat Kuruchittham,et al.  The Wisconsin Breast Cancer Epidemiology Simulation Model. , 2006, Journal of the National Cancer Institute. Monographs.

[119]  Phyllis Butow,et al.  A systematic review on communicating with patients about evidence. , 2006, Journal of evaluation in clinical practice.

[120]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .

[121]  J B Wong,et al.  Analytic Choices in Economic Models of Treatments for Rheumatoid Arthritis: What Makes a Difference? , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[122]  A. Panlilio,et al.  Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[123]  S. Domchek,et al.  Patients' resistance to risk information in genetic counseling for BRCA1/2. , 2005, Archives of internal medicine.

[124]  M. Mahoney.  Publication prejudices: An experimental study of confirmatory bias in the peer review system , 1977, Cognitive Therapy and Research.

[125]  B. Robberstad.  QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting? , 2005 .

[126]  A. Dhar,et al.  National Institute for Health and Clinical Excellence , 2005 .

[127]  R. Haynes,et al.  Optimal search strategies for retrieving systematic reviews from Medline: analytical survey , 2004, BMJ : British Medical Journal.

[128]  Yen Lin Chia,et al.  Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration , 2004, Statistical methods in medical research.

[129]  F. Pang,et al.  Generalisability in economic evaluation studies in healthcare: a review and case studies. , 2004, Health technology assessment.

[130]  Peter J. Neumann,et al.  Using cost-effectiveness analysis to improve health care: opportunities and barriers. , 2004 .

[131]  J. Brazier,et al.  The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.

[132]  A. Rothberg.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2008 .

[133]  Anthony J Culyer,et al.  National Institute for Clinical Excellence and its value judgments , 2004, BMJ : British Medical Journal.

[134]  Ronald M Epstein,et al.  Communicating evidence for participatory decision making. , 2004, JAMA.

[135]  N. Facione,et al.  Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. , 2004, Preventive medicine.

[136]  P Barton,et al.  The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. , 2004, Health technology assessment.

[137]  A E Ades,et al.  Expected Value of Sample Information Calculations in Medical Decision Modeling , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[138]  H. Valdimarsdottir,et al.  Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers , 2003, Journal of Genetic Counseling.

[139]  Martin L. Brown,et al.  Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature , 2004, Breast Cancer Research and Treatment.

[140]  Joshua A Salomon,et al.  Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data , 2003, Population health metrics.

[141]  Rob Baltussen,et al.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .

[142]  P. Bossuyt,et al.  BMC Medical Research Methodology , 2002 .

[143]  S. Love,et al.  Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methods , 2003, British Journal of Cancer.

[144]  A. Briggs,et al.  Probabilistic Sensitivity Analysis for Decision Trees with Multiple Branches: Use of the Dirichlet Distribution in a Bayesian Framework , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[145]  M. Donaldson,et al.  Cost-effectiveness targets for multi-detector row CT angiography in the work-up of patients with intermittent claudication. , 2003, Radiology.

[146]  R. Rosenfeld,et al.  Evidence-Based Otitis Media , 2003 .

[147]  T P Klassen,et al.  The inclusion of reports of randomised trials published in languages other than English in systematic reviews. , 2003, Health technology assessment.

[148]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.

[149]  M. Drummond,et al.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE) , 2002, The Lancet.

[150]  Ron Goeree,et al.  Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[151]  John B Wong,et al.  Pharmacogenomics of hepatitis C and decision analysis: A glimpse into the future , 2002, Hepatology.

[152]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[153]  T J Ulahannan,et al.  Decision Making in Health and Medicine: Integrating Evidence and Values , 2002 .

[154]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice; Users' Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice , 2003, BMJ : British Medical Journal.

[155]  T Stijnen,et al.  Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. , 2001, Radiology.

[156]  H. Gravelle,et al.  Discounting for health effects in cost-benefit and cost-effectiveness analysis. , 2001, Health economics.

[157]  J. Fox-Rushby,et al.  Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. , 2001, Health Policy and Planning.

[158]  M G Hunink,et al.  In Search of Tools to Aid Logical Thinking and Communicating about Medical Decision Making , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[159]  P J Neumann,et al.  An Off-the-Shelf Help List , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[160]  M. Hunink,et al.  Cost and patency rate targets for the development of endovascular devices to treat femoropopliteal arterial disease. , 2001, Radiology.

[161]  A. O'Hagan,et al.  Bayesian calibration of computer models , 2001 .

[162]  J. Wong,et al.  Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis , 2000, Annals of Internal Medicine.

[163]  A. Tversky,et al.  Choices, Values, and Frames , 2000 .

[164]  M. Binder,et al.  Comparing Three-class Diagnostic Tests by Three-way ROC Analysis , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[165]  W. Kannel,et al.  The Framingham Study: ITS 50-year legacy and future promise. , 2000, Journal of atherosclerosis and thrombosis.

[166]  R. Jackson,et al.  Updated New Zealand cardiovascular disease risk-benefit prediction guide , 2000, BMJ : British Medical Journal.

[167]  P. Priest,et al.  Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated , 2000, BMJ : British Medical Journal.

[168]  Daniel McFadden,et al.  Rationality for Economists , 1999 .

[169]  John W. Payne,et al.  Measuring Constructed Preferences: Towards a Building Code , 1999 .

[170]  M G Hunink,et al.  Noninvasive Imaging for the Diagnosis of Coronary Artery Disease: Focusing the Development of New Diagnostic Technology , 1999, Annals of Internal Medicine.

[171]  C. Schmitt,et al.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. , 1999 .

[172]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[173]  A J Moskowitz,et al.  Bayesian estimation of cost-effectiveness ratios from clinical trials. , 1999, Health economics.

[174]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[175]  M. Segal,et al.  Meta-analysis of exercise testing to detect coronary artery disease in women. , 1999, The American journal of cardiology.

[176]  A. Cull,et al.  The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress , 1999, British Journal of Cancer.

[177]  Susan R. Wilson,et al.  Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews , 1998, BMJ.

[178]  S. Jansen,et al.  Patients' Utilities for Cancer Treatments , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[179]  Ralph L. Keeney,et al.  Book Reviews : Scientific Opportunities and Public Needs: Improv ing Priority Setting and Public Input at the National Institutes of Health. Institute of Medicine. Washington, DC: National Academy Press, 1998, 136 pages, $26.00 , 1998 .

[180]  P. Pattynama,et al.  Cost-effective diagnostic algorithms in pulmonary embolism: an updated analysis. , 1998, Academic radiology.

[181]  M C Weinstein,et al.  Uncertainty in Decision Models Analyzing Cost-Effectiveness , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[182]  A. Kühberger,et al.  The Influence of Framing on Risky Decisions: A Meta-analysis. , 1998, Organizational behavior and human decision processes.

[183]  F. Harrell,et al.  Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. WHO/ARI Young Infant Multicentre Study Group. , 1998, Statistics in medicine.

[184]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[185]  S. Mennemeyer,et al.  A bootstrap approach to medical decision analysis. , 1997, Journal of health economics.

[186]  D. Kleinbaum,et al.  Regression models for ordinal responses: a review of methods and applications. , 1997, International journal of epidemiology.

[187]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[188]  K. Fleming,et al.  Evidence-based pathology , 1997, Evidence Based Medicine.

[189]  M. Johannesson,et al.  Incorporating Future Costs in Medical Cost-Effectiveness Analysis , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[190]  J Lipscomb,et al.  Assessing Uncertainty in Cost-Effectiveness Analyses , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[191]  A H Briggs,et al.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.

[192]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[193]  Alan D. Lopez,et al.  Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study , 1997, The Lancet.

[194]  D Polsky,et al.  Confidence intervals for cost-effectiveness ratios: a comparison of four methods. , 1997, Health economics.

[195]  L. Goldman,et al.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. , 1997, JAMA.

[196]  David O. Meltzer,et al.  Accounting for future costs in medical cost-effectiveness analysis. , 1997 .

[197]  A. Garber,et al.  Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.

[198]  M. Johannesson,et al.  The Validity of QALYs , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[199]  J. Birkmeyer,et al.  Cost-effectiveness of carotid endarterectomy in asymptomatic patients. , 1997, Journal of vascular surgery.

[200]  J. Richardson,et al.  The importance of Perspective in the Measurement of Quality-adjusted Life Years , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[201]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[202]  D. Kleinbaum.  Survival Analysis: A Self-Learning Text , 1997 .

[203]  E. Mackenzie,et al.  The development of the Functional Capacity Index. , 1996, The Journal of trauma.

[204]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[205]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[206]  M. Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[207]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[208]  Amiram Gafni,et al.  When Do the "Dollars" Make Sense? , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[209]  P. Wakker,et al.  A Criticism of Healthy-years Equivalents , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[210]  S. Stearns,et al.  Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1996, Statistics in medicine.

[211]  D. Feeny,et al.  Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. , 1996, Medical care.

[212]  P. Dolan,et al.  Valuing health states: a comparison of methods. , 1996, Journal of health economics.

[213]  A. Gafni,et al.  Time preference, the discounted utility model and health. , 1996, Journal of health economics.

[214]  David R. Holtgrave,et al.  Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. , 1996, Public health reports.

[215]  A. Elstein,et al.  Valuing the Future , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[216]  P. Wakker,et al.  Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.

[217]  D. Vlahov,et al.  Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. , 1995, American journal of epidemiology.

[218]  M A Koopmanschap,et al.  The friction cost method for measuring indirect costs of disease. , 1995, Journal of health economics.

[219]  M. Weinstein,et al.  Life Expectancy Biases in Clinical Decision Modeling , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[220]  Erry,et al.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.

[221]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[222]  D. Redelmeier,et al.  Medical decision making in situations that offer multiple alternatives. , 1995, JAMA.

[223]  G W Torrance,et al.  Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.

[224]  M. Ruffin,et al.  Patients' interpretation of qualitative probability statements. , 1994, Archives of family medicine.

[225]  F. O. Hoffman,et al.  Propagation of uncertainty in risk assessments: the need to distinguish between uncertainty due to lack of knowledge and uncertainty due to variability. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[226]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[227]  A. Woodward,et al.  Screening for colorectal cancer using an immunochemical test for faecal occult blood: results of the first 2 years of a South Australian programme. , 1994, The Australian and New Zealand journal of surgery.

[228]  D. Timmermans,et al.  The Roles of Experience and Domain of Expertise in Using Numerical and Verbal Probability Terms in Medical Decisions , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[229]  M. Johannesson,et al.  A Note on QALYs, Time Tradeoff, and Discounting , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[230]  K C Cain,et al.  Measuring Preferences for Health States Worse than Death , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[231]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[232]  L E Moses,et al.  Estimating Diagnostic Accuracy from Multiple Conflicting Reports , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[233]  J R Beck,et al.  Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[234]  D A Redelmeier,et al.  Time Preference in Medical Decision Making and Cost - Effectiveness Analysis , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[235]  D A Redelmeier,et al.  Understanding patients' decisions. Cognitive and emotional perspectives. , 1993, JAMA.

[236]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[237]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[238]  H Raiffa,et al.  Decision Analysis: Introductory Lectures on Choices under Uncertainty. , 1969 .

[239]  BOMBAY CALCUrIA,et al.  World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.

[240]  P. Musgrove.  Investing in health: the 1993 World Development Report of the World Bank. , 1993, Bulletin of the Pan American Health Organization.

[241]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[242]  K. Dickersin,et al.  Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. , 1992, JAMA.

[243]  D. Kahneman,et al.  Anomalies: The Endowment Effect, Loss Aversion, and Status Quo Bias , 1991 .

[244]  D. Kahneman,et al.  Experimental Tests of the Endowment Effect and the Coase Theorem , 1990, Journal of Political Economy.

[245]  P R Dear,et al.  How do parents of babies interpret qualitative expressions of probability? , 1990, Archives of disease in childhood.

[246]  D. Chakraborty,et al.  Free-response methodology: alternate analysis and a new observer-performance experiment. , 1990, Radiology.

[247]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[248]  J B McKinlay,et al.  Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed? , 1989, American journal of public health.

[249]  A. Mushlin,et al.  Focusing Technology Assessment Using Medical Decision Theory , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.

[250]  J. Hanley.  The Robustness of the "Binormal" Assumptions Used in Fitting ROC Curves , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.

[251]  R M Kaplan,et al.  A general health policy model: update and applications. , 1988, Health services research.

[252]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[253]  K. Richter,et al.  Multiple Classification and Receiver Operating Characteristic (ROC) Analysis , 1987, Medical decision making : an international journal of the Society for Medical Decision Making.

[254]  J. Puylaert,et al.  A prospective study of ultrasonography in the diagnosis of appendicitis. , 1987, The New England journal of medicine.

[255]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[256]  R. Simes,et al.  Confronting publication bias: a cohort design for meta-analysis. , 1987, Statistics in medicine.

[257]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[258]  K E Willard,et al.  Probabilistic sensitivity analysis methods for general decision models. , 1986, Computers and biomedical research, an international journal.

[259]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[260]  B. McNeil,et al.  Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.

[261]  Baruch Fischhoff,et al.  Characterizing Perceived Risk , 1985 .

[262]  S G Pauker,et al.  Kidney Failure or Cancer , 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

[263]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[264]  F. Harrell,et al.  Estimating the likelihood of significant coronary artery disease. , 1983, The American journal of medicine.

[265]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[266]  E. Keeler,et al.  Discounting of Life-Saving and Other Nonmonetary Effects , 1983 .

[267]  R. Sugden,et al.  Regret Theory: An alternative theory of rational choice under uncertainty Review of Economic Studies , 1982 .

[268]  M. Beers,et al.  The Merck Manual of Diagnosis and Therapy , 1982 .

[269]  J R Beck,et al.  A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. , 1982, The American journal of medicine.

[270]  A. Tversky,et al.  On the elicitation of preferences for alternative therapies. , 1982, The New England journal of medicine.

[271]  Averill M. Law,et al.  Simulation Modeling and Analysis , 1982 .

[272]  A. Tversky,et al.  The framing of decisions and the psychology of choice. , 1981, Science.

[273]  M. Weinstein,et al.  Clinical Decision Analysis , 1980 .

[274]  J. Kassirer,et al.  The threshold approach to clinical decision making. , 1980, The New England journal of medicine.

[275]  Joseph S. Pliskin,et al.  Utility Functions for Life Years and Health Status , 1980, Oper. Res..

[276]  A. Tversky,et al.  Prospect Theory : An Analysis of Decision under Risk Author ( s ) : , 2007 .

[277]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[278]  R. Rosenthal.  The file drawer problem and tolerance for null results , 1979 .

[279]  J. Swets.  ROC analysis applied to the evaluation of medical imaging techniques. , 1979, Investigative radiology.

[280]  A. Tversky,et al.  Prospect theory: analysis of decision under risk , 1979 .

[281]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[282]  W. M. Schmidt.  Health and welfare of Colonial American children. , 1976, American journal of diseases of children.

[283]  J. Kassirer,et al.  Therapeutic decision making: a cost-benefit analysis. , 1975, The New England journal of medicine.

[284]  A. Tversky,et al.  Judgment under Uncertainty: Heuristics and Biases , 1974, Science.

[285]  Allen Newell,et al.  Human Problem Solving. , 1973 .

[286]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.

[287]  D. Dorfman,et al.  Maximum likelihood estimation of parameters of signal detection theory—A direct solution , 1968, Psychometrika.

[288]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[289]  John G. Kemeny,et al.  Finite Markov chains , 1960 .

[290]  G. A. Miller.  THE PSYCHOLOGICAL REVIEW THE MAGICAL NUMBER SEVEN, PLUS OR MINUS TWO: SOME LIMITS ON OUR CAPACITY FOR PROCESSING INFORMATION 1 , 1956 .

[291]  M. Allais.  Le comportement de l'homme rationnel devant le risque : critique des postulats et axiomes de l'ecole americaine , 1953 .

[292]  J. Neumann,et al.  Theory of games and economic behavior , 1945, 100 Years of Math Milestones.

[293]  E. C. Fieller.  THE DISTRIBUTION OF THE INDEX IN A NORMAL BIVARIATE POPULATION , 1932 .